Persistent Asset Partners »

Edgewise Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 11k 1096.49
2025-12-31 $526k 21k 24.82

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Paradigm Biocapital Advisors
Baker Bros. Advisors
BlackRock
Henderson Group
Novo A/S
Vanguard Group
Siren
Perceptive Advisors
Driehaus Capital Management
Vanguard Capital Management
Cormorant Asset Management
Braidwell
Morgan Stanley

View all funds holding Edgewise Therapeutics